Aussies access Biogen ALS drug

By Megan Brodie 3 years ago | In Cell and gene therapies, Companies, Products
  • 3 years ago

26 May 2021 All Australian patients included in a phase 3 study of a first-in-class…

This is subscriber-only content. Please login to continue reading.